The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption available to commercial health insurers for anticompetitive conduct. “The AHA believes that the commercial health insurance industry should be governed by the same antitrust laws and policies that apply in other sectors of our economy, including hospitals and other health care providers,” AHA said in a letter to Sen. Steve Daines, R-Mont., and Rep. Peter DeFazio, D-Ore., the lead sponsors of the legislation. “Any exemptions should be narrow and carefully tailored to achieve a pro-competitive purpose. We have previously articulated our concerns to the Department of Justice’s Antitrust Division about the abuse of market power by large commercial insurers; this remains a concern as large commercial insurers continue attempts to consolidate to the detriment of consumers.”

Headline
The Centers for Medicare & Medicaid Services Nov. 13 announced it will delay enforcement of its Medicaid community engagement requirements that are set for…
Headline
The Department of Health and Human Services Nov. 12 made two announcements  regarding the development of mental health treatments for veterans and other…
Headline
Bill Gassen, president and CEO of Sanford Health and AHA chair-elect, will participate in a panel discussion during the 2026 Milken Institute Future of Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
A new AHA blog examines a Department of Health and Human Services issue brief that claims Medicaid hospital provider taxes increase employer-sponsored…